首頁 > 市場調查報告書 > 醫療設備

傷口護理

市場調查報告書

商品編碼

1347969

全球傷口護理市場 - 2023-2030

Global Wound Care Market - 2023-2030

出版日期: 2023年09月11日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

全球傷口護理市場在 2022 年達到 185 億美元，預計到 2030 年將達到 254 億美元，2023-2030 年預測期間年複合成長率為 4.5%。

傷口護理主要集中於治療壓瘡、糖尿病足潰瘍、皮膚撕裂、手術傷口和燒傷以及其他一般傷口。全球傷口護理市場正在受到產品推出和批准數量增加的推動。此外，糖尿病足潰瘍和壓瘡等慢性傷口的患病率不斷增加，交通事故和自然災害等造成的外傷病例也不斷增加。

預計北美地區將在市場佔有率中佔據重要地位。糖尿病足潰瘍領域佔有重要的市場佔有率。用於治療疾病的產品的批准和疾病患病率的增加使該細分市場處於重要地位。

動力學

產品發布數量的增加預計將推動市場成長

預計產品發布數量的增加將推動市場成長。例如，2023年6月13日，贏創公司JeNaCell推出了傷口敷料Epicite Balance，用於腿部靜脈性潰瘍、腿部動脈性潰瘍、糖尿病足潰瘍、壓瘡和軟組織病變等慢性傷口。 Epicite 天平有三種不同的尺寸，將通過 Coopmed ApS 公司分發給醫院和家庭護理中心。

此外，2022 年 10 月 10 日，總部位於班加羅爾的 Healthium Medtech 推出了新的傷口敷料組合 Theruptor Novo，用於治療糖尿病足潰瘍和腿部潰瘍等慢性傷口。隨著 Theruptor Novo 的推出，Healthium 增強了其在先進傷口敷料領域現有的專利產品組合。因此，產品發布數量的增加預計將推動市場成長。

主要公司的戰略預計將推動市場成長

收購、合作和夥伴關係等策略加強了市場成長。這些公司的戰略預計將推動市場成長。例如，2023 年 5 月 10 日，LifeNet Health 收購了 Bioventus Inc. 傷口護理部門，擴大了其傷口護理解決方案組合，添加了 TheraSkin 等革命性產品。這一舉措鞏固了 LifeNet Health 作為再生醫學領域全球領導者的地位，提供更高水平的傷口護理。

這些公司的收購預計也將加速市場成長。例如，2023 年 7 月 7 日，康樂保達成協議，以高達 13 億美元（約 89 億丹麥克朗）收購冰島傷口護理公司 Kerecis，原因是該公司在美國生物製品行業的成長潛力所吸引。因此，公司戰略預計將推動市場成長。

傷口護理產品的高成本將限制市場成長

傷口護理產品成本的上漲是市場擴張的主要障礙。這是由於原料和勞動力價格上漲，導致敷料、繃帶、消毒劑和其他產品等傷口護理用品的成本增加。許多人買不起高成本、先進的傷口護理產品，這可能會阻礙市場的成長。例如，ActiGraft 4 週內的產品成本在 1,710 美元到 3,780 美元之間。

Overview

Global Wound Care Market reached US$ 18.5 billion in 2022 and is expected to reach US$ 25.4 billion by 2030, growing with a CAGR of 4.5% during the forecast period 2023-2030.

Wound care has been focussed mainly on treating pressure ulcers, diabetic foot ulcers, skin tears, surgical wounds and burns, and other general wounds. The global wound care market is being driven by the increased number of launches of the products and their approvals. Additionally, there is an increased prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, as well as the rising occurrences of trauma cases, such as those caused by vehicle accidents and natural disasters.

The North America region is expected to hold a significant position in the market share. The diabetic foot ulcers segment holds a significant market share. The approvals of the products in managing the condition and the increase in the prevalence of the disease are holding the segment in a significant position.

Dynamics

Increased Number of Product Launches is Expected to Drive the Market Growth

An increased number of product launches are expected to drive the market growth. For instance, on June 13, 2023, Evonik company JeNaCell launched a wound dressing Epicite balance for chronic wounds, such as venous leg ulcers, arterial leg ulcers, diabetic foot ulcers, pressure ulcers, and soft tissue lesions. Epicite balance comes in three different sizes and will be distributed through the company Coopmed ApS to hospitals and homecare centers.

Additionally, on 10 October 2022, Bengaluru-based Healthium Medtech launched a new wound dressing portfolio Theruptor Novo for the management of chronic wounds like diabetic foot ulcers and leg ulcers. With the launch of Theruptor Novo, Healthium strengthens its existing portfolio of patented products in the advanced wound dressing segment. Thus, an increase in the number of product launches is expected to drive the market growth.

Strategies by the Key Companies are Expected to Drive Market Growth

Strategies such as acquisitions, collaborations, and partnerships strengthen the market growth. The strategies by the companies are expected to drive the market growth. For instance, on May 10, 2023, LifeNet Health expanded its portfolio of wound care solutions, adding revolutionary products such as TheraSkin, with the acquisition of the Bioventus Inc. wound care division. This step strengthens LifeNet Health's position as a global leader in regenerative medicine, offering next-level wound care.

Acquisition of the companies is also expected to accelerate the market growth. For instance, on July 7, 2023, Coloplast came to an agreement to acquire Kerecis, an Icelandic wound care company, for up to $1.3 billion (around DKK 8.9 billion), attracted by the company's assumed growth potential in the United States biologics sector. Thus, the company strategies are expected to drive the market growth.

High Cost of Wound Care Products will Restrict the Market Growth

The rising cost of wound care products is a major hindrance to the market's expansion. This is due to increased raw material and labor prices, which are increasing the cost of wound care items such as dressings, bandages, antiseptics, and other products. High-cost, advanced wound care products cannot be afforded by many individuals, which can hamper the market growth. For instance, ActiGraft had a product cost ranging from $1,710 to $3,780 over 4 weeks.

Segment Analysis

The global wound care market is segmented based on product, wound type, end-user, and region.

Diabetic Foot Ulcers Segment Holds a Significant Position in the Market Share

An increase in the prevalence of diabetic foot ulcers is expected to hold the segment growth. For instance, according to NIH, approximately 18.6 million people worldwide are affected by diabetic foot ulcers each year, including 1.6 million people in the United States. These ulcers precede 80% of lower extremity amputations among people diagnosed with diabetes and are associated with an increased risk of death.

Additionally, diabetic foot ulcers were found in 4.54% of patients newly diagnosed with type 2 diabetes mellitus in India, and the prevalence of DFS at the primary care level in Germany is 2.9%. Thus, these factors are expected to hold the segment growth.

Geographical Penetration

North America Region Holds the Largest Market Share in the Global Wound Care Market

North America is expected to hold a dominant share of the market. The increase in the number of launches is expected to hold the region in a significant position. The presence of major players and an increased number of product launches are expected to drive the region's market share. For instance, on 3 January 2023, Convatec announced the US launch of ConvaFoam, a family of advanced foam dressings designed to address the needs of healthcare providers and their patients. ConvaFoam can be used on a spectrum of wound types at any stage of the wound journey, making it the simple dressing choice for wound management and skin protection.

Additionally, on July 18, 2023, RedDress Medical launched ActiGraft PRO with G-Code reimbursement status for the US wound Care market. Thus, the high number of approvals and launches of the products is holding the region in a significant position.

Competitive Landscape

The global wound care market is fragmented, with the presence of many local and international players. Smith & Nephew PLC., Molnlycke Health Care Ab, Baxter International Inc., Acelity L.P. Inc., Integra Lifesciences, Holding Corporation, Coloplast A/S, Ethicon Inc, 3 M, Medline Industries, LP., and Convatec Group. are the leading Companies with a significant market share.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global wound care market. COVID-19 pandemic caused disruption in the manufacturing of wound care products. The availability of wound care products has been reduced due to the outbreak of the pandemic.

As the coronavirus rapidly spread, medical attention shifted to treating COVID-affected patients while protecting others from infection. Patients became apprehensive about seeking wound care due to shelter-in-place orders and concerns about contracting the coronavirus. Thus, COVID-19 has impacted the market growth negatively.

Key Developments

On MARCH 3, 2023, Bactiguard released a broad range of infection prevention solutions, from a unique coating technology to a portfolio of coated medical devices. The portfolio also includes biocompatible and effective wound care products, which are now launched in the UK and Ireland.

By Product

Advanced Wound Dressings
Surgical Wound Dressings
Traditional Wound Dressings
Film Dressings
Alginate Dressings
Hydrogel Dressings
Others

By Wound Type

Diabetic Foot Ulcers
Pressure Ulcers
Surgical & Traumatic Wounds
Venous Leg Ulcers
Burns
Other Wounds

By End-User

Hospitals
Specialty Clinics
Home Care Settings
Others

By Region

North America
- U.S.
- Canada
- Mexico

Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe

South America
- Brazil
- Argentina
- Rest of South America

Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific

Middle East and Africa

Why Purchase the Report?

To visualize the global wound care market segmentation based on product, wound type, end-user, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of wound care market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global wound care market report would provide approximately 61 tables, 58 figures, and 186 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by Wound Type
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increased number of product launches
  - 4.1.1.2. Strategies by the key companies
- 4.1.2. Restraints
  - 4.1.2.1. High cost of wound care products
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 7.1.2. Market Attractiveness Index, By Product
7.2. Advanced Wound Dressings *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Surgical Wound Dressings
7.4. Traditional Wound Dressings
7.5. Film Dressings
7.6. Alginate Dressings
7.7. Hydrogel Dressings
7.8. Others

8. By Wound Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 8.1.2. Market Attractiveness Index, By Wound Type
8.2. Diabetic Foot Ulcers *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Pressure Ulcers
8.4. Surgical & Traumatic Wounds
8.5. Venous Leg Ulcers
8.6. Burns
8.7. Other Wounds

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Home Care Settings
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Smith & Nephew PLC. *
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Molnlycke Health Care Ab
12.3. Baxter International Inc.
12.4. Acelity L.P. Inc.
12.5. Integra Lifesciences Holding Corporation
12.6. Coloplast A/S
12.7. Ethicon Inc
12.8. 3M
12.9. Medline Industries, LP.
12.10. Convatec Group.

LIST NOT EXHAUSTIVE